MARY ENDRESON: Open Payments
NPI 1457690265 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 19 payments from 10 companies in 2025. Trend: 2023 $206 · 2024 $131 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $179 |
| GENZYME CORPORATION | 2 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $35 |
| Galderma Laboratories, L.P. | 1 | $32 |
| Amgen Inc. | 1 | $30 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $24 |
| Incyte Corporation | 1 | $24 |
| Biofrontera Inc. | 1 | $17 |
Products named: TREMFYA, DUPIXENT, COSENTYX, ILUMYA, NEMLUVIO, OTEZLA, OPZELURA, AMELUZ.
Industry payments across FL — which companies pay providers there.
